Is CVM or DNA more undervalued in 2026?

CirclFi compares Cel-Sci Corporation (CVM) and Ginkgo Bioworks Holdings, Inc. (DNA) using 13 institutional-grade valuation models. CVM has a Quality of Company score of 3.3/10 while DNA scores 6.1/10.

Which is a better buy — CVM or DNA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CVM and DNA valuations compare?

CVM at $1.54 and DNA at $9.37 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CVM vs DNA Valuation Comparison 2026 — Intrinsic Value Analysis

CVM

Biological Products, (No Diagnostic Substances)

Cel-Sci Corporation

Quality

3.3

out of 10

Value Trap

SAFE

Price

$1.54

Last close

Models

7/13

Active

DNA

Biological Products, (No Diagnostic Substances)

Ginkgo Bioworks Holdings, Inc.

Quality

6.1

out of 10

Value Trap

SAFE

Price

$9.37

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	CVM Fair Value	CVM Upside	DNA Fair Value	DNA Upside
Bayesian DCF	Intrinsic	$0.03	-98.0%	$0.13	-98.6%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.12	-94.8%	$0.57	-92.9%
Dynamic NAV	Asset-Based	$1.75	+13.6%	$3.29	-64.9%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CVM vs DNA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CVM vs DNA — Which Stock Is More Undervalued?

DNA scores higher with a 6.1/10 quality rating vs CVM's 3.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Cel-Sci Corporation (CVM) and Ginkgo Bioworks Holdings, Inc. (DNA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CVM currently trades at $1.54 with a QOC of 3.3/10, while DNA trades at $9.37 with a QOC of 6.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).